Patents by Inventor Marcio Falci

Marcio Falci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for growing tissue with Lopap-based pharmaceutical compositions
    Patent number: 8673840
    Abstract: The invention refers to pharmaceutical compositions and cosmetic compositions comprising a prophylactic or therapeutically effective quantity of at least one polypeptide substantially identical to Lopap (a lipocalin-related protein with prothrombin activating protease activity). The invention refers to the use of these compositions as modulators of cell death and anti-aging agents.
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: March 18, 2014
    Assignees: Biolabs Sanus Farmaceutica Ltda., Fundacao de Amparao a Pesquisa do Estado de Sao Paulo-Fapesp
    Inventors: Ana Marisa Chudzinski-Tavassi, Marcio Falci, Cleyson Valenca Reis, Durvanei Augusto Maria
  • PHARMACEUTICAL COMPOSITION COMPRISING RACETAM AND CARNITINE AND PROCESS FOR ITS PREPARATION
    Publication number: 20110052556
    Abstract: The present invention refers to a pharmaceutical composition comprising racetam and carnitine. Said pharmaceutical composition may further comprise coenzyme Q10 and/or agent associated with mitochondrial and/or metabolic disturbance, such as hypocholesterolemic agent of the statins group, a hypoglycemic agent, or an antiepileptic agent. The invention also includes a method of treatment for mitochondrial disturbances comprising administration of the pharmaceutical composition of the invention.
    Type: Application
    Filed: February 27, 2009
    Publication date: March 3, 2011
    Applicant: Biolab Sanus Farmaceutical Ltda
    Inventors: José Roberto da Costa Perreira, Marcio Falci, Mauricio Matteis Alario
  • LOPAP-BASED PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
    Publication number: 20090170182
    Abstract: The invention refers to pharmaceutical compositions and cosmetic compositions comprising a prophylactic or therapeutically effective quantity of at least one polypeptide substantially identical to Lopap (a lipocalin-related protein with prothrombin activating protease activity). The invention refers to the use of these compositions as modulators of cell death and anti-aging agents.
    Type: Application
    Filed: September 8, 2006
    Publication date: July 2, 2009
    Inventors: Ana Marisa Chudzinski-Tavassi, Marcio Falci, Cleyson Valenca Reis, Durvanel Augusto Maria
  • Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers
    Patent number: 7147859
    Abstract: It relates to an Association of chemical agents, with intended pharmacological action to prevent the risk of infarction and brain hemorrhage caused by the development of the atherosclerotic process and of the homocysteinemia resulting from ageing. It is of the utmost importance to prevent the increase of endogenous homocysteine. High levels of homocysteine in blood, caused by genetical error and further biologic circumstances impart damaging consequences upon the human organism (occlusion of blood vessels, ocular modifications, osteoporosis and nervous system).
    Type: Grant
    Filed: June 10, 2002
    Date of Patent: December 12, 2006
    Assignee: Laboratorios Biosintetica LTDA.
    Inventors: Roberto Luis Bruno, Marcio Falci
  • Application of phytosteroids (and isomers thereof), folic acid, cyanocobalamine and pyridoxine in dietetic (alimentary) fibers
    Publication number: 20060039932
    Abstract: The present invention relates to an Association of chemical agents (namely, phytosteroids (and isomers thereof), folic acids, cyanocobalamine and pyridoxine in dietetic(alimentary) fibers), with intended pharmacological action to prevent the risk of infarction and brain hemorrhage caused by the development of the atherosclerotic process and of the homocysteinemia resulting from ageing. It is of the utmost importance to prevent the increase of endogenous homocysteine. High levels of homocysteine in blood, caused by genetical error and further biologic circumstances imparts damaging consequences upon the human organism (occlusion of blood vessels, ocular modifications, osteoporosis, nervous system).
    Type: Application
    Filed: October 6, 2004
    Publication date: February 23, 2006
    Applicant: Laboratorios Biosintetica Ltda.
    Inventors: Roberto Penteado, Marcio Falci
  • Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers
    Publication number: 20030133965
    Abstract: It relates to an Association of chemical agents, with intended pharmacological action to prevent the risk of infarction and brain hemorrhage caused by the development of the atherosclerotic process and of the homocysteinemia resulting from ageing.
    Type: Application
    Filed: June 10, 2002
    Publication date: July 17, 2003
    Inventors: Roberto Luis Bruno, Marcio Falci
  • Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
    Publication number: 20030103955
    Abstract: The present application refers to a new pharmaceutical composition of diclofenac comprising the following formulation: PAPAIN . . . 0.1 to 15%, HYALURONIDASE . . . 50 to 900 utr/mg, VITAMIN E . . . 10 to 2000 mg.
    Type: Application
    Filed: November 14, 2002
    Publication date: June 5, 2003
    Inventors: Cristiano A.R. Santana, Gilberto De Nucci, Marcio Falci
  • Application of phytosteroids(and isomers thereof), folic acid, cyanocobalamine and pyridoxine in dietetic (alimentary) fibers
    Publication number: 20020018811
    Abstract: It relates to an Association of chemical agents, with intended pharmacological action to prevent the risk of infarction and brain hemorrhage caused by the development of the atherosclerotic process and of the homocysteinemia resulting from ageing.
    Type: Application
    Filed: May 14, 2001
    Publication date: February 14, 2002
    Inventors: Roberto Luiz Bruno Penteado, Marcio Falci